The largest database of trusted experimental protocols

Norvir

Manufactured by Abbott
Sourced in Canada

Norvir is a pharmaceutical product manufactured by Abbott. It is a protease inhibitor medication used in the treatment of HIV infection. Norvir works by inhibiting the activity of HIV protease, an enzyme essential for the replication of the virus.

Automatically generated - may contain errors

2 protocols using norvir

1

Oral Docetaxel and Ritonavir Pharmacokinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the clinical studies, docetaxel was administered to patients as drinking solution (iv formulation, Taxotere®, Rhone‐Poulenc Rorer/Aventis), capsules (ModraDoc001 10 mg capsules, Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute), or tablets (ModraDoc006 10 mg capsules, Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute). Ritonavir was administered as tablets (Norvir®; Abbott). Patients received orally 30 to 80 mg of docetaxel coadministered with ritonavir at a dose of 100 or 200 mg according to a weekly schema. Patients were fasted 2 hours before and 1 hour after oral drug administration to minimize variation in absorption.
+ Open protocol
+ Expand
2

Antiretroviral Drug Dissolution and Application

Check if the same lab product or an alternative is used in the 5 most similar protocols
APV and LPV for in-vitro experiments were purchased from Toronto Research Chemicals Inc (Ontario, Canada). Both antiretroviral drugs were dissolved in dimethyl sulfoxide (DMSO Hybri-Max; Sigma, Oakville, Ontario, Canada). FosAPV (oral Lexiva; ViiV Healthcare, Laval, Quebec, Canada), ritonavir (oral Norvir; Abbott Laboratories, Edmonton, Alberta, Canada) and LPV/ritonavir (oral Kaletra; Abbott Laboratories) were used for in-vivo studies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!